"Cervia II working group report 2006":: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy
"Cervia II working group report 2006":: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy
复制标题
DOI：
10.1016/j.dld.2007.05.016
复制
发表时间：
2007-08-01
影响因子：
4.5
通讯作者：
Gasbarrini, G.
中科院分区：
文献类型：
--
作者：
Caselli, M.;Zullo, A.;Gasbarrini, G.
在临床实践中对幽门螺杆菌感染进行适当的管理--当得到循证数据的支持时--有望产生实质性的成本效益优势。这一考虑促使塞尔维亚工作组组织了一次专家会议，以更新H.意大利的幽门螺杆菌感染。新欧洲指南中的建议是在国家背景下考虑的，这里考虑的因素包括胃癌和胃淋巴瘤的发病率、不同诊断工具的可及性、细菌对抗生素耐药性的普遍性以及不同药物的可用性。对以前准则的主要修订包括H.在非溃疡性消化不良患者和非甾体类抗炎药使用者以及特发性血小板减少性紫癜和缺铁性贫血患者中根除幽门螺杆菌。粪便抗原试验现在被接受为确认H的有效试验。治疗后根除幽门螺杆菌。新的治疗方法已被推荐用于一线（序贯治疗）和二线（以左氧氟沙星为基础）治疗。(C)2007年意大利胃肠病学编辑由爱思唯尔有限公司出版。保留所有权利。
Proper management of Helicobacter pylori infection in clinical practice - when supported by evidence-based data - is expected to produce substantial cost-efficacy advantages. This consideration has prompted the Cervia Working Group to organise a meeting of experts to update the National Guidelines on the diagnosis and treatment of H. pylori infection in Italy. Recommendations in the new European Guidelines were considered in the National setting, here in the light of factors such as the incidence of gastric cancer and gastric lymphoma, the accessibility to different diagnostic tools, the prevalence of bacterial resistance against antibiotics, and the availability of different drugs. The main revisions in respect to the previous guidelines include H. pylori eradication in non-ulcer dyspepsia patients and in non-steroidal, anti-inflammatory drug users, as well as in patients with idiopathic thrombocytopenic purpura and iron deficiency anaemia. The stool antigen test is now accepted as a valid test for confirmation of H. pylori eradication following therapy. New therapeutic approaches have been recommended for both first(sequential therapy) and second-line (levofloxacin-based) treatment in our country. (C) 2007 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.